Cargando…

Bioengineering of a tumour-stroma 3D-tumouroid co-culture model of hypopharyngeal cancer

Head and neck cancer (HNC) differs at anatomical sites and hypopharyngeal cancer (HPC) is a type of HNC. The non-surgical treatment option for advanced cases of HPC is radiotherapy (RT) with or without chemotherapy but survival is poor. Thus, new treatment approaches in combination with RT are essen...

Descripción completa

Detalles Bibliográficos
Autores principales: Saha, Santu, Howarth, Rachel, Sharma-Saha, Sweta, Kelly, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214853/
https://www.ncbi.nlm.nih.gov/pubmed/37194999
http://dx.doi.org/10.1242/bio.059949
_version_ 1785047926725148672
author Saha, Santu
Howarth, Rachel
Sharma-Saha, Sweta
Kelly, Charles
author_facet Saha, Santu
Howarth, Rachel
Sharma-Saha, Sweta
Kelly, Charles
author_sort Saha, Santu
collection PubMed
description Head and neck cancer (HNC) differs at anatomical sites and hypopharyngeal cancer (HPC) is a type of HNC. The non-surgical treatment option for advanced cases of HPC is radiotherapy (RT) with or without chemotherapy but survival is poor. Thus, new treatment approaches in combination with RT are essential. Yet, obtaining post-RT treated tumour specimens and lack of animal models with identical anatomical sites are the major translational research barriers. To overcome these barriers, for the first time, we have developed a tumour-stroma based in vitro three-dimensional (3D)-tumouroid co-culture model of HPC by growing FaDu and HS-5 cells together to mimic the complex tumour-microenvironment in a Petri dish. Before growing the cells together, imaging flow cytometry revealed distinct epithelial and non-epithelial characteristics of the cells. Growth rate of the 3D-tumouroid co-culture was significantly higher compared to the tumouroid monoculture of FaDu. Histology and morphometric analysis were done for the characterisation as well as the development of hypoxia was measured by CAIX immunostaining in this 3D-tumouroid co-culture. Taken together, this innovative in vitro 3D model of HPC resembles many features of the original tumour. The wider application of this pre-clinical research tool is in understanding newer combination (e.g. immunotherapy) treatment approaches with RT in HPC and beyond.
format Online
Article
Text
id pubmed-10214853
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-102148532023-05-27 Bioengineering of a tumour-stroma 3D-tumouroid co-culture model of hypopharyngeal cancer Saha, Santu Howarth, Rachel Sharma-Saha, Sweta Kelly, Charles Biol Open Methods & Techniques Head and neck cancer (HNC) differs at anatomical sites and hypopharyngeal cancer (HPC) is a type of HNC. The non-surgical treatment option for advanced cases of HPC is radiotherapy (RT) with or without chemotherapy but survival is poor. Thus, new treatment approaches in combination with RT are essential. Yet, obtaining post-RT treated tumour specimens and lack of animal models with identical anatomical sites are the major translational research barriers. To overcome these barriers, for the first time, we have developed a tumour-stroma based in vitro three-dimensional (3D)-tumouroid co-culture model of HPC by growing FaDu and HS-5 cells together to mimic the complex tumour-microenvironment in a Petri dish. Before growing the cells together, imaging flow cytometry revealed distinct epithelial and non-epithelial characteristics of the cells. Growth rate of the 3D-tumouroid co-culture was significantly higher compared to the tumouroid monoculture of FaDu. Histology and morphometric analysis were done for the characterisation as well as the development of hypoxia was measured by CAIX immunostaining in this 3D-tumouroid co-culture. Taken together, this innovative in vitro 3D model of HPC resembles many features of the original tumour. The wider application of this pre-clinical research tool is in understanding newer combination (e.g. immunotherapy) treatment approaches with RT in HPC and beyond. The Company of Biologists Ltd 2023-05-17 /pmc/articles/PMC10214853/ /pubmed/37194999 http://dx.doi.org/10.1242/bio.059949 Text en © 2023. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle Methods & Techniques
Saha, Santu
Howarth, Rachel
Sharma-Saha, Sweta
Kelly, Charles
Bioengineering of a tumour-stroma 3D-tumouroid co-culture model of hypopharyngeal cancer
title Bioengineering of a tumour-stroma 3D-tumouroid co-culture model of hypopharyngeal cancer
title_full Bioengineering of a tumour-stroma 3D-tumouroid co-culture model of hypopharyngeal cancer
title_fullStr Bioengineering of a tumour-stroma 3D-tumouroid co-culture model of hypopharyngeal cancer
title_full_unstemmed Bioengineering of a tumour-stroma 3D-tumouroid co-culture model of hypopharyngeal cancer
title_short Bioengineering of a tumour-stroma 3D-tumouroid co-culture model of hypopharyngeal cancer
title_sort bioengineering of a tumour-stroma 3d-tumouroid co-culture model of hypopharyngeal cancer
topic Methods & Techniques
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214853/
https://www.ncbi.nlm.nih.gov/pubmed/37194999
http://dx.doi.org/10.1242/bio.059949
work_keys_str_mv AT sahasantu bioengineeringofatumourstroma3dtumouroidcoculturemodelofhypopharyngealcancer
AT howarthrachel bioengineeringofatumourstroma3dtumouroidcoculturemodelofhypopharyngealcancer
AT sharmasahasweta bioengineeringofatumourstroma3dtumouroidcoculturemodelofhypopharyngealcancer
AT kellycharles bioengineeringofatumourstroma3dtumouroidcoculturemodelofhypopharyngealcancer